Whole-Exome Sequencing Identifies Novel GATA5/6 Variants in Right-Sided Congenital Heart Defects

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2025 Mar 13

PMID 40076735

Authors

Gloria K E Zodanu

John H Hwang

Jordan Mudery

Carlos Sisniega

Xuedong Kang

Lee-Kai Wang

Alexander Barsegian

Reshma M Biniwale

Ming-Sing Si

Nancy J Halnon

Ucla Congenital Heart Defects-BioCore Faculty

Wayne W Grody

Gary M Satou

Glen S Van Arsdell

Stanly F Nelson

Marlin Touma

Affiliations

Soon will be listed here.

Abstract

One out of every hundred live births present with congenital heart abnormalities caused by the aberrant development of the embryonic cardiovascular system. The conserved zinc finger transcription factor proteins, which include GATA binding protein 5 (GATA5) and GATA binding protein (GATA6) play important roles in embryonic development and their inactivation may result in congenital heart defects (CHDs). In this study, we performed genotypic-phenotypic analyses in two families affected by right-sided CHD diagnosed by echocardiography imaging. Proband A presented with pulmonary valve stenosis, and proband B presented with complex CHD involving the right heart structures. For variant detection, we employed whole-genome single-nucleotide polymorphism (SNP) microarray and family-based whole-exome sequencing (WES) studies. Proband A is a full-term infant who was admitted to the neonatal intensive care unit (NICU) at five days of life for pulmonary valve stenosis (PVS). Genomic studies revealed a normal SNP microarray; however, quad WES analysis identified a novel heterozygous [Chr20:g.61041597C>G (p.Arg237Pro)] variant in the gene. Further analysis confirmed that the novel variant was inherited from the mother but was absent in the father and the maternal uncle with a history of heart murmur. Proband B was born prematurely at 35 weeks gestation with a prenatally diagnosed complex CHD. A postnatal evaluation revealed right-sided heart defects including pulmonary atresia with intact ventricular septum (PA/IVS), right ventricular hypoplasia, tricuspid valve hypoplasia, hypoplastic main and bilateral branch pulmonary arteries, and possible coronary sinusoids. Cardiac catheterization yielded anatomy and hemodynamics unfavorable to repair. Hence, heart transplantation was indicated. Upon genomic testing, a normal SNP microarray was observed, while trio WES analysis identified a novel heterozygous [Chr18:c.1757C>T (p.Pro586Leu)] variant in the gene. This variant was inherited from the father, who carries a clinical diagnosis of tetralogy of Fallot. These findings provide new insights into novel variants, elaborate on the genotypic and phenotypic association, and highlight the critical role of GATA5 and GATA6 transcription factors in a wide spectrum of right-sided CHDs.

References

Suzuki E, Evans T, Lowry J, Truong L, BELL D, Testa J . The human GATA-6 gene: structure, chromosomal location, and regulation of expression by tissue-specific and mitogen-responsive signals. Genomics. 1996; 38(3):283-90. DOI: 10.1006/geno.1996.0630. View

LaVoie H . The role of GATA in mammalian reproduction. Exp Biol Med (Maywood). 2003; 228(11):1282-90. DOI: 10.1177/153537020322801107. View

Song Z, Yan B . Potential roles of GATA binding protein 5 in cardiovascular diseases. Rev Cardiovasc Med. 2020; 21(2):253-261. DOI: 10.31083/j.rcm.2020.02.5104. View

Sun Z, Cui Y, Yan B . Identification of two novel GATA6 mutations in an adult with acute myocardial infarction, diabetes, and atrial fibrillation: a case report. J Geriatr Cardiol. 2019; 16(10):785-788. PMC: 6828608. DOI: 10.11909/j.issn.1671-5411.2019.10.009. View

Tucker N, Mahida S, Ye J, Abraham E, Mina J, Parsons V . Gain-of-function mutations in GATA6 lead to atrial fibrillation. Heart Rhythm. 2016; 14(2):284-291. DOI: 10.1016/j.hrthm.2016.10.014. View

Xu L, Zhao L, Yuan F, Jiang W, Liu H, Li R . GATA6 loss-of-function mutations contribute to familial dilated cardiomyopathy. Int J Mol Med. 2014; 34(5):1315-22. DOI: 10.3892/ijmm.2014.1896. View

Wei D, Bao H, Zhou N, Zheng G, Liu X, Yang Y . GATA5 loss-of-function mutation responsible for the congenital ventriculoseptal defect. Pediatr Cardiol. 2012; 34(3):504-11. DOI: 10.1007/s00246-012-0482-6. View

Tremblay M, Sanchez-Ferras O, Bouchard M . GATA transcription factors in development and disease. Development. 2018; 145(20). DOI: 10.1242/dev.164384. View

Benhaourech S, Drighil A, El Hammiri A . Congenital heart disease and Down syndrome: various aspects of a confirmed association. Cardiovasc J Afr. 2016; 27(5):287-290. PMC: 5370349. DOI: 10.5830/CVJA-2016-019. View

10.

Aronson B, Stapleton K, Krasinski S . Role of GATA factors in development, differentiation, and homeostasis of the small intestinal epithelium. Am J Physiol Gastrointest Liver Physiol. 2014; 306(6):G474-90. PMC: 3949026. DOI: 10.1152/ajpgi.00119.2013. View

11.

Sailani M, Makrythanasis P, Valsesia A, Santoni F, Deutsch S, Popadin K . The complex SNP and CNV genetic architecture of the increased risk of congenital heart defects in Down syndrome. Genome Res. 2013; 23(9):1410-21. PMC: 3759718. DOI: 10.1101/gr.147991.112. View

12.

Yasuhara J, Manivannan S, Majumdar U, Gordon D, Lawrence P, Aljuhani M . Novel pathogenic GATA6 variant associated with congenital heart disease, diabetes mellitus and necrotizing enterocolitis. Pediatr Res. 2023; 95(1):146-155. PMC: 11800323. DOI: 10.1038/s41390-023-02811-y. View

13.

Goswami C, Chattopadhyay A, Chuang E . Rare variants: data types and analysis strategies. Ann Transl Med. 2021; 9(12):961. PMC: 8267277. DOI: 10.21037/atm-21-1635. View

14.

Zhang X, Dai N, Tang K, Chen Y, Chen W, Wang J . GATA5 loss-of-function mutation in familial dilated cardiomyopathy. Int J Mol Med. 2014; 35(3):763-70. DOI: 10.3892/ijmm.2014.2050. View

15.

Yan S, Jiao K . Functions of miRNAs during Mammalian Heart Development. Int J Mol Sci. 2016; 17(5). PMC: 4881605. DOI: 10.3390/ijms17050789. View

16.

Kablak-Ziembicka A, Badacz R, Okarski M, Wawak M, Przewlocki T, Podolec J . Cardiac microRNAs: diagnostic and therapeutic potential. Arch Med Sci. 2023; 19(5):1360-1381. PMC: 10507763. DOI: 10.5114/aoms/169775. View

17.

Plana M, Zamora J, Suresh G, Fernandez-Pineda L, Thangaratinam S, Ewer A . Pulse oximetry screening for critical congenital heart defects. Cochrane Database Syst Rev. 2018; 3:CD011912. PMC: 6494396. DOI: 10.1002/14651858.CD011912.pub2. View

18.

Fahed A, Gelb B, Seidman J, Seidman C . Genetics of congenital heart disease: the glass half empty. Circ Res. 2013; 112(4):707-20. PMC: 3827691. DOI: 10.1161/CIRCRESAHA.112.300853. View

19.

Wang J, Luo X, Xin Y, Liu Y, Liu Z, Wang Q . Novel GATA6 mutations associated with congenital ventricular septal defect or tetralogy of fallot. DNA Cell Biol. 2012; 31(11):1610-7. PMC: 3482375. DOI: 10.1089/dna.2012.1814. View

20.

Sri Krishna S, Majumdar I, Grishin N . Structural classification of zinc fingers: survey and summary. Nucleic Acids Res. 2003; 31(2):532-50. PMC: 140525. DOI: 10.1093/nar/gkg161. View